Isomorphic Labs, a drug discovery spinout of Google DeepMind, has reportedly raised $5 billion to develop new medicines using AI, six months after securing $2.1 billion. The company says its technology is already producing encouraging early results in cancer and immune disease research.
Google DeepMind spinout Isomorphic Labs raises $5 billion for AI drug discoveryAI News
Isomorphic Labs, a drug discovery spinout of Google DeepMind, has reportedly raised $5 billion to develop new medicines using AI, six months after securing $2.1 billion. The company says its technology is already producing encouraging early results in cancer and immune disease research.
